首页 | 本学科首页   官方微博 | 高级检索  
     

卵巢癌和胰腺癌患者血清CA125、CA199的水平相关分析
引用本文:王兰君,李国兴,王秀民. 卵巢癌和胰腺癌患者血清CA125、CA199的水平相关分析[J]. 放射免疫学杂志, 2007, 20(1): 68-69
作者姓名:王兰君  李国兴  王秀民
作者单位:河南省新乡医学院第一附属医院,453100;河南省新乡医学院第一附属医院,453100;河南省新乡医学院第一附属医院,453100
摘    要:目的:研究血清CA125和CA199的测定对卵巢疾病和胰腺疾病诊断的临床意义.方法:发光免疫分析测定了50例正常对照组,95例卵巢疾病和67例胰腺疾病患者血清中CA125和CA199的水平.结果:卵巢癌与胰腺癌患者的血清CA125和CA199水平较对照组显著升高(P<0.001).结论:血清CA125和CA199联合测定对诊断和鉴别卵巢癌和胰腺癌有一定的临床价值.

关 键 词:发光免疫分析  糖类抗原125  糖类抗原199
收稿时间:2006-11-09
修稿时间:2006-12-04

Study on the Serum Levels of CA125 and CA199 in Patients with Ovarian or Pancreatic Cancers
Wang Lanjun,Li Guoxing,Wang Xiumin. Study on the Serum Levels of CA125 and CA199 in Patients with Ovarian or Pancreatic Cancers[J]. Journal of Radioimmanology, 2007, 20(1): 68-69
Authors:Wang Lanjun  Li Guoxing  Wang Xiumin
Abstract:Objective To study the clinical significance of determining serum CA125 and CA199 levels in patients with ovarian or pancreatic cancer.Methods Serum CA125 and CA199 levels were determined with CLIA in 50 controls,95 patients with ovarian diseases(benign 56, malignant 39) and 67 patients with pancreatic disease(benign 31,malignant 36).Results The levels of CA125 and CA199 in patients with ovarian and pancreatic cancer were significantly highter than those in controls (P<0.001).Conclusion Combined determination of serum levels of CA125 and CA199 was a valuable method for the clinical and differential diagnosis of ovary and pancreatic cancers.
Keywords:luminescent CA125 CA199
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号